Four new languages added to Dripmate

Dripmate strives for being user-friendly and to be available on the market in the language our client is most comfortable with – therefore, we are happy to announce that Dripmate’s language availability from Danish, English and French has now been upgraded to Dutch, German, Italian and Spanish.

Welcome to the new R&D Engineer

We are very happy to welcome and announce our new R&D Engineer, Finn Beldring. Finn is a mechanical engineer, who has previously worked with industrial product development. His experience and knowledge are the reason behind hiring him. We are looking forward for his contribution and for a long and beneficial collaboration.

Dripmate

Dripmate is an innovative newly developed device for continuous intravenous medication. Continuous intravenous medication is one of the most widely used treatments in hospitals worldwide.

Dripmate solves a number of challenges related to the traditional continuous intravenous treatment. With Dripmate, a more accurate intravenous dosage can be performed, hereby assuring that patients receiving Dripmate for intravenous treatment receive the correct amount of medicine. In traditional intravenous treatment, more than 20% of the treatments have a stop.

Dripmate will address and minimize these unplanned treatment stops, thus achieving prompt intervention by the staff. Associated personnel will also be able to monitor more patients during continuous intravenous treatment using Dripmate than with the current traditional method, since Dripmate provides both audio and visual alarms. Thus, with the use of Dripmate, a significant qualitative improvement is achieved, while at the same time achieving substantial resource savings.

Dripmate is a unique Medical Device, as no calibration or ongoing maintenance is required.

Dripmate A/S is developed in Denmark. Was established in 2007 and is today a limited company in which Carsten Berger is CEO. Dripmate A / S consists of a professional board with Arne Kaae as chairman of the board, as well as Karsten Lollike, Bo Eklund, Henrik Oehlenschlæger and Carsten Berger as other board members.

Arne Kaae and Carsten Berger have been in the company since its establishment in 2007. Arne Kaae has been chairman of the board throughout the period while Carsten Berger has been Board menber and Carsten Berger has been a consultant. Carsten Berger has been CEO since the beginning of 2017.

Carsten Berger is a major shareholder in the company.

Dripmate A/S is located in Symbion, a development house with approx. 300 other new innovative companies. Symbion is located at Fruebjergvej 3, 2100 Copenhagen Ø.

Dripmate A / S was CE certified in 2017 under EU Directive 93/42 / EEC on Medical Devices, as well as Danish Executive Order No. 1263 of 15 December 2008. Quality system was developed and meets ISO13485: 2016 as Dripmate was certified for September 27 2017, and earlier, quality system was certified and filled ISO13485: 2012.

Dripmate - Medical Device

Sign up for newsletter: